Analystreport

BioXcel Therapeutics, Inc. (NASDAQ: BTAI) is now covered by analysts at Berenberg Bank. They set a "buy" rating on the stock.

BioXcel Therapeutics, Inc.  (BTAI) 
Last bioxcel therapeutics, inc. earnings: 11/14 07:00 am Check Earnings Report